Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Continuing the Resplendence with 20 Years' Glory, CPhI China Welcomes the Golden Year of Chinese Pharma 2019-12-03 16:54
New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority 2019-12-03 05:30
Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly 2019-12-02 09:37
Innovent Biologics Announces FDA Acceptance of NDA for Pemigatinib in Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusions or Rearrangements 2019-12-02 08:00
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication 2019-11-29 20:22
Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout 2019-11-29 08:00
Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL) 2019-11-28 12:10
Mundipharma CEO Raman Singh Wins Executive of The Year at SBR Management Excellence Awards 2019-11-28 12:00
Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050 2019-11-28 00:34
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-PD-1/HER2 Bispecific Antibody in China 2019-11-27 07:50
New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease 2019-11-27 02:31
Japan and Singapore Grant CRISPR Patents to Merck 2019-11-26 21:00
Xinhua Silk Road: Er-Kang highly recognized for "going global" achievements in Cambodia 2019-11-25 18:16
Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050 2019-11-25 08:15
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference 2019-11-25 07:00
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland 2019-11-23 01:55
Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China 2019-11-22 23:50
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years 2019-11-21 23:05
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park 2019-11-21 11:30
NeuroVive Pharmaceutical AB Interim Report January - September 2019 2019-11-20 16:38
1 311 312 313 314 315 412